HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,751,000 | +280.4% | 582,094 | +364.9% | 0.00% | +200.0% |
Q3 2016 | $1,512,000 | +36.7% | 125,196 | -2.3% | 0.00% | 0.0% |
Q2 2016 | $1,106,000 | -9.4% | 128,116 | -0.6% | 0.00% | 0.0% |
Q1 2016 | $1,221,000 | -39.3% | 128,945 | +11.2% | 0.00% | 0.0% |
Q4 2015 | $2,010,000 | +64.1% | 115,989 | +27.1% | 0.00% | 0.0% |
Q3 2015 | $1,225,000 | -36.2% | 91,246 | +7.4% | 0.00% | 0.0% |
Q2 2015 | $1,919,000 | +72.1% | 84,970 | +8.8% | 0.00% | 0.0% |
Q1 2015 | $1,115,000 | +82.2% | 78,068 | +23.2% | 0.00% | – |
Q4 2014 | $612,000 | +36.9% | 63,379 | +29.1% | 0.00% | – |
Q3 2014 | $447,000 | -8.8% | 49,100 | -1.1% | 0.00% | – |
Q2 2014 | $490,000 | -61.1% | 49,652 | -50.0% | 0.00% | -100.0% |
Q1 2014 | $1,261,000 | -1.9% | 99,213 | +15.6% | 0.00% | 0.0% |
Q4 2013 | $1,286,000 | +49.9% | 85,827 | +10.5% | 0.00% | 0.0% |
Q3 2013 | $858,000 | -16.7% | 77,662 | -40.0% | 0.00% | 0.0% |
Q2 2013 | $1,030,000 | – | 129,476 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |